{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:03:41Z","timestamp":1790690621828,"version":"4.1.0"},"reference-count":25,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDR"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n<jats:title>Aims:<\/jats:title>\n<jats:p>The present study aimed to compare the pregnancy outcomes, efficacy, and safety\nof faster aspart with insulin aspart among Indian women with gestational diabetes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>In several countries, fast-acting insulin aspart (faster aspart) has been approved for\nuse in pregnancy. There is a lack of data related to maternal glycemic control and fetal and perinatal\noutcomes with faster aspart in gestational diabetes among the Indian population.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>To compare and evaluate the efficacy and safety of faster aspart and insulin aspart in the\nmanagement of gestational diabetes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This retrospective study evaluated the medical records of 60 pregnant women diagnosed\nwith gestational diabetes and managed with faster aspart or insulin aspart at a tertiary care center,\nbetween March 2019 and September 2020. Self-monitored blood glucose levels recorded at 4\ntimepoints (fasting, and 1 hour post breakfast, lunch, and dinner) during 6 consecutive days any\ntime before delivery were analyzed. Pregnancy and neonatal outcomes across both groups were\ncompared.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The mean postprandial glucose value following dinner was significantly lesser in the faster\naspart group compared to the insulin aspart group (123.61 \u00b1 2.52 mg\/dL vs. 125.87 \u00b1 2.98\nmg\/dL, respectively; p=0.0024). Women in the faster aspart group had significantly lower glycemic\nvariability (fluctuations). Lesser number of hypoglycemic events were noted in the faster aspart\ngroup (10 vs 20; p=0.0595).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Faster aspart was associated with better glycemic control compared to insulin aspart\namong women with gestational diabetes. Further large-scale studies are needed to validate the outcomes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573399819666221222154443","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T04:03:04Z","timestamp":1672027384000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and Safety of Faster Aspart in Comparison to Insulin Aspart\nAmong Indian Women with Gestational Diabetes"],"prefix":"10.2174","volume":"19","author":[{"given":"Aneesh","family":"Ghosh","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Ananthapuri Hospitals and Research Institute, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.2337\/dc21-S014","volume":"44","year":"2021","unstructured":"14. Management of diabetes in pregnancy: Standards of medical care in diabetes-2021. Diabetes Care American Diabetes Association2021,44(S1),S200-S210","journal-title":"Diabetes Care"},{"key":"ref=2","year":"2021","unstructured":"International Diabetes FederationAvailable from: 2021"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e2025074","DOI":"10.1001\/jamanetworkopen.2020.25074","volume":"3","author":"Swaminathan G.","year":"2020","unstructured":"Swaminathan G.; Swaminathan A.; Corsi D.J.; Prevalence of gestational diabetes in India by individual socioeconomic, demographic, and clinical factors. JAMA Netw Open 2020,3(11),e2025074","journal-title":"JAMA Netw Open"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5455\/ijmsph.2013.211120131","volume":"3","author":"Raja M.","year":"2014","unstructured":"Raja M.; Baba T.; Hanga A.; A study to estimate the prevalence of gestational diabetes mellites in an urban block of Kashmir valley (North India). Int J Med Sci Public Health 2014,3(2),191-195","journal-title":"Int J Med Sci Public Health"},{"key":"ref=5","first-page":"707","volume":"52","author":"Seshiah V.","year":"2004","unstructured":"Seshiah V.; Balaji V.; Balaji M.S.; Sanjeevi C.B.; Green A.; Gestational diabetes mellitus in India. J Assoc Physicians India 2004,52,707-711","journal-title":"J Assoc Physicians India"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"186.e1","DOI":"10.1016\/j.ajog.2007.08.005","volume":"198","author":"Hod M.","year":"2008","unstructured":"Hod M.; Damm P.; Kaaja R.; Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 2008,198(2),186.e1-186.e7","journal-title":"Am J Obstet Gynecol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1097\/AOG.0b013e31829277f5","volume":"121","author":"Figueroa D.","year":"2013","unstructured":"Figueroa D.; Landon M.B.; Mele L.; Relationship between 1-hour glucose challenge test results and perinatal outcomes. Obstet Gynecol 2013,121(6),1241-1247","journal-title":"Obstet Gynecol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.jp.7211243","volume":"25","author":"Weisz B.","year":"2005","unstructured":"Weisz B.; Shrim A.; Homko C.J.; Schiff E.; Epstein G.S.; Sivan E.; One hour versus two hours postprandial glucose measurement in gestational diabetes: a prospective study. J Perinatol 2005,25(4),241-244","journal-title":"J Perinatol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"B131","DOI":"10.2337\/diacare.21.11.1978","volume":"21","author":"Jovanovic L.","year":"1998","unstructured":"Jovanovic L.; American diabetes association\u2019s fourth international workshop-conference on gestational diabetes mellitus: summary and discussion. Therapeutic interventions. Diabetes Care 1998,21(S2),B131-B137","journal-title":"Diabetes Care"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0020-7292(95)90312-7","volume":"48","year":"1995","unstructured":"Diabetes and pregnancy. Int J Gynaecol Obstet Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists1995,48(3),331-339","journal-title":"Int J Gynaecol Obstet"},{"key":"ref=11","first-page":"16","volume":"65","author":"Gangopadhyay K.K.","year":"2017","unstructured":"Gangopadhyay K.K.; Mukherjee J.J.; Sahay R.K.; Consensus on use of insulins in gestational diabetes. J Assoc Physicians India 2017,65(3),16-22","journal-title":"J Assoc Physicians India"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11095-019-2578-7","volume":"36","author":"Kildegaard J.","year":"2019","unstructured":"Kildegaard J.; Buckley S.T.; Nielsen R.H.; Elucidating the mechanism of absorption of fast-acting insulin aspart: The role of niacinamide. Pharm Res 2019,36(3),49","journal-title":"Pharm Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.5603\/DK.2018.0031","volume":"7","author":"Cypryk K.","year":"2019","unstructured":"Cypryk K.; Wyr\u0119bska-Niew\u0119g\u0142owska A.; New faster-acting insulin Fiasp\u00ae - do we need a new meal-time insulin? Clinical Diabetology 2019,7(6),282-286","journal-title":"Clinical Diabetology"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2337\/dc16-1771","volume":"40","author":"Russell-Jones D.","year":"2017","unstructured":"Russell-Jones D.; Bode B.W.; De Block C.; Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: Results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial (onset 1). Diabetes Care 2017,40(7),943-950","journal-title":"Diabetes Care"},{"key":"ref=15","first-page":"118","author":"Jebasing F.K.","year":"2020","unstructured":"Jebasing F.K.; Thomas N.;  RSSDI\u2019s Insulin Monograph (A Complete Guide to Insulin Therapy) 2020,118-119","journal-title":"RSSDI\u2019s Insulin Monograph (A Complete Guide to Insulin Therapy)"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"SUN-LB117","DOI":"10.1210\/jendso\/bvaa046.2115","volume":"4","author":"Bhattacharyya S.","year":"2020","unstructured":"Bhattacharyya S.; SUN-LB117 faster acting insulin aspart in patients with gestational diabetes mellitus - an early experience from India. J Endocr Soc 2020,4(S1),SUN-LB117","journal-title":"J Endocr Soc"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"Battelino T.","year":"2019","unstructured":"Battelino T.; Danne T.; Bergenstal R.M.; Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care 2019,42(8),1593-1603","journal-title":"Diabetes Care"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1111\/dom.13270","volume":"20","author":"Basu A.","year":"2018","unstructured":"Basu A.; Pieber T.R.; Hansen A.K.; Greater early postprandial suppression of endogenous glucose production and higher initial glucose disappearance is achieved with fast\u2010acting insulin aspart compared with insulin aspart. Diabetes Obes Metab 2018,20(7),1615-1622","journal-title":"Diabetes Obes Metab"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jcjd.2019.01.004","volume":"43","author":"Senior P.","year":"2019","unstructured":"Senior P.; Hramiak I.; Fast-acting insulin aspart and the need for new mealtime insulin analogues in adults with type 1 and type 2 diabetes: A Canadian perspective. Can J Diabetes 2019,43(7),515-523","journal-title":"Can J Diabetes"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s13300-019-00685-0","volume":"10","author":"Evans M.","year":"2019","unstructured":"Evans M.; Wilkinson M.; Giannpolou A.; Fast-acting insulin aspart: The rationale for a new mealtime insulin. Diabetes Ther 2019,10(5),1793-1800","journal-title":"Diabetes Ther"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13098-020-00529-z","volume":"12","author":"Gabbay M.A.L.","year":"2020","unstructured":"Gabbay M.A.L.; Rodacki M.; Calliari L.E.; Time in range: A new parameter to evaluate blood glucose control in patients with diabetes. Diabetol Metab Syndr 2020,12(1),22","journal-title":"Diabetol Metab Syndr"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2337\/dc16-1770","volume":"40","author":"Bowering K.","year":"2017","unstructured":"Bowering K.; Case C.; Harvey J.; Faster aspart versus insulin aspart as part of a basal-bolus regimen in inadequately controlled type 2 diabetes: The onset 2 trial. Diabetes Care 2017,40(7),951-957","journal-title":"Diabetes Care"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.2337\/dc19-2232","volume":"43","author":"Lane W.S.","year":"2020","unstructured":"Lane W.S.; Favaro E.; Rathor N.; A randomized trial evaluating the efficacy and safety of fast-acting insulin aspart compared with insulin aspart, both in combination with insulin degludec with or without metformin, in adults with type 2 diabetes (ONSET 9). Diabetes Care 2020,43(8),1710-1716","journal-title":"Diabetes Care"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1111\/dom.13545","volume":"20","author":"Buse J.B.","year":"2018","unstructured":"Buse J.B.; Carlson A.L.; Komatsu M.; Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial. Diabetes Obes Metab 2018,20(12),2885-2893","journal-title":"Diabetes Obes Metab"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e045650","DOI":"10.1136\/bmjopen-2020-045650","volume":"11","author":"Norgaard S.K.","year":"2021","unstructured":"Norgaard S.K.; Mathiesen E.R.; N\u00f8rgaard K.; Faster-acting insulin Fiasp versus insulin NovoRapid in the treatment of women with type 1 or type 2 diabetes during pregnancy andlactation - a randomised controlled trial. BMJ Open 2021,11(4),e045650","journal-title":"BMJ Open"}],"container-title":["Current Diabetes Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399819666221222154443","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/212124\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399819666221222154443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T12:41:43Z","timestamp":1694176903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/212124\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573399819666221222154443","relation":{},"ISSN":["1573-3998"],"issn-type":[{"value":"1573-3998","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e221222212124"}}